PTC Therapeutics Inc CHMP Opinion on Translarna Call Transcript - Thomson StreetEvents

PTC Therapeutics Inc CHMP Opinion on Translarna Call Transcript

PTC Therapeutics Inc CHMP Opinion on Translarna Call Transcript - Thomson StreetEvents
PTC Therapeutics Inc CHMP Opinion on Translarna Call Transcript
Published Sep 15, 2023
12 pages (6804 words) — Published Sep 15, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of PTCT.OQ conference call or presentation 15-Sep-23 12:45pm GMT

  
Brief Excerpt:

...Operator Good day, and thank you for standing by. Welcome to today's conference call CHMP opinion on Translarna. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your host today, Ron Aldridge, Senior Director, Investor Relations. Please go ahead. Ron Aldridge Good morning, and thank you for joining us today to discuss the CHMP opinion on Translarna. I'm joined today by our Chief Executive Officer, Dr. Matthew Klein. Today's call will include forward-looking statements based on our current expectations, including with respect to PTC's plans for interactions with the European Medicines Agency and the outcome of any reexamination process. Please take a moment to review the press release that we issued this morning, which contains more information regarding forward-looking statements. Our actual results could materially differ from these forward-looking statements, as such statements are subject to risks that...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
PTC Therapeutics Inc
Ticker
PTCT.OQ
Time
12:45pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Kristen Brianne Kluska - Cantor Fitzgerald & Co., Research Division - Analyst : Sorry to hear about this news. I wanted to ask you, on the flip side of the data that you've collected showing the benefits across Translarna. And do you also have any studies or findings or sense of what would essentially happen to some of these effects if patients were to stop taking the treatment given there are very few options available for them. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. SEPTEMBER 15, 2023 / 12:45PM, PTCT.OQ - PTC Therapeutics Inc CHMP Opinion on Translarna Call

Question: Kristen Brianne Kluska - Cantor Fitzgerald & Co., Research Division - Analyst : Okay. And to that point, I'm wondering how you're going to think about collecting some of these anecdotes hearing from key thought leaders as you reengage with the agency over the next couple of months, especially as some of these patients, you're talking about over 5, 6 years on consistent therapy.

Table Of Contents

PTC Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript – 2024-09-05 – US$ 54.00 – Edited Transcript of PTCT.OQ presentation 5-Sep-24 1:15pm GMT

PTC Therapeutics Inc Q2 2024 Earnings Call Transcript – 2024-08-08 – US$ 54.00 – Edited Transcript of PTCT.OQ earnings conference call or presentation 8-Aug-24 8:30pm GMT

PTC Therapeutics Inc To Host PIVOT-HD 12-Month Interim Results Transcript – 2024-06-20 – US$ 54.00 – Edited Transcript of PTCT.OQ conference call or presentation 20-Jun-24 12:00pm GMT

PTC Therapeutics Inc Annual Shareholders Meeting Transcript – 2024-06-18 – US$ 54.00 – Edited Transcript of PTCT.OQ shareholder or annual meeting 18-Jun-24 1:00pm GMT

PTC Therapeutics Inc Q3 2023 Earnings Call Transcript – 2023-10-26 – US$ 54.00 – Edited Transcript of PTCT.OQ earnings conference call or presentation 26-Oct-23 8:30pm GMT

PTC Therapeutics Inc at Citi BioPharma Conference Transcript – 2023-09-06 – US$ 54.00 – Edited Transcript of PTCT.OQ presentation 6-Sep-23 1:40pm GMT

PTC Therapeutics Inc Q2 2023 Earnings Call Transcript – 2023-08-03 – US$ 54.00 – Edited Transcript of PTCT.OQ earnings conference call or presentation 3-Aug-23 8:30pm GMT

PTC Therapeutics Inc Phenylketonuria (PKU) and Sepiapterin - Corporate Call Transcript – 2023-07-19 – US$ 54.00 – Edited Transcript of PTCT.OQ conference call or presentation 19-Jul-23 4:00pm GMT

PTC Therapeutics Inc PIVOT-HD Interim Data Update Call Transcript – 2023-06-21 – US$ 54.00 – Edited Transcript of PTCT.OQ conference call or presentation 21-Jun-23 12:00pm GMT

PTC Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript – 2023-06-14 – US$ 54.00 – Edited Transcript of PTCT.OQ presentation 14-Jun-23 5:40pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "PTC Therapeutics Inc CHMP Opinion on Translarna Call Transcript" Sep 15, 2023. Alacra Store. May 24, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/PTC-Therapeutics-Inc-CHMP-Opinion-on-Translarna-Call-T15744575>
  
APA:
Thomson StreetEvents. (2023). PTC Therapeutics Inc CHMP Opinion on Translarna Call Transcript Sep 15, 2023. New York, NY: Alacra Store. Retrieved May 24, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/PTC-Therapeutics-Inc-CHMP-Opinion-on-Translarna-Call-T15744575>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.